Drug intelligence / Profile preview

NSupple

Development stage: Preclinical
Lead developer: Efeom Nutrition
Administration: Oral

Overview

NSupple is a nutraceutical formulation designed to support microbiota and elicit clinical improvements in metabolic diseases. It contains a blend of prebiotics (fructooligosaccharides (FOS), galactooligosaccharides (GOS), yeast β-glucans) and minerals (magnesium, selenium, zinc). The formulation aims to modulate the gut microbiota, enhance sleep quality, improve quality of life, and positively influence cardiometabolic and inflammatory markers, particularly in overweight/obese individuals. It is distinguished from NSupple_Silybum by the absence of Silybum marianum (Silymarin) extract.

Beyond the preview

Go deeper on NSupple.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NSupple.

Explore the full profile